Moderna taps Singapore, Hong Kong for COVID era expansion

Taiwan, Malaysia also picked; CEO Bancel eyes vaccine plants in Asia

20220216 moderna

Moderna, which developed one of the main COVID-19 vaccines used worldwide, is looking to begin production in Asia. (Source photo by Akira Kodaka and Reuters)

DYLAN LOH, Nikkei staff writer

SINGAPORE -- COVID-19 vaccine maker Moderna will expand into Singapore, Hong Kong, Taiwan and Malaysia this year to better serve the Asian market, where its shots continue to be used to battle the coronavirus pandemic.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.